Hutchin Hill Capital’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GE
FLAM
NCGI
CRC
JHIU
DCM
GIM
Hutchin Hill Capital's NEO Position: Q1 2017 in Review
Hutchin Hill Capital sold out of NeoGenomics (NEO) in Q1 2017, closing a stake of 54,900 shares — an estimated $470K sold.
Hutchin Hill Capital first reported a position in NEO in Q4 2016 and held it in 1 quarter. The position peaked at $470K in Q4 2016. 143 funds tracked by Wall St. Rank hold NEO as of Q1 2017.
- Hutchin Hill Capital reported no remaining NeoGenomics position as of Q1 2017 after selling out during the quarter.
- Hutchin Hill Capital sold 54,900 NeoGenomics shares in Q1 2017, an estimated $470K.
- Hutchin Hill Capital first reported a position in NeoGenomics in Q4 2016 and held it in 1 quarter.
- Hutchin Hill Capital's NeoGenomics position peaked at $470K in Q4 2016.
- 143 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2017.
Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.